NP-Supported Multidisciplinary Diabetes Management During Perioperative Period
NPMDM-PP
1 other identifier
interventional
170
0 countries
N/A
Brief Summary
The primary objective of this study is to determine the benefits of interventions from a Multidisciplinary Diabetes Care team involved of diabetes nurse practitioners(DNP) on glucose control, perioperative outcomes and psychosocial outcomes for patients with Diabetes Mellitus
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes
Started Apr 2022
Shorter than P25 for not_applicable diabetes
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2021
CompletedFirst Posted
Study publicly available on registry
March 23, 2022
CompletedStudy Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2023
CompletedMarch 23, 2022
December 1, 2021
12 months
December 29, 2021
March 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
EFFICACY: TIR(Time in Range)
Time in range
From into the group to the first hospital day; First day in hospital to the day of discharge
Secondary Outcomes (9)
EFFICACY: Glycated Serum Protein
baseline and 1 month after discharged
EFFICACY: Incidence of perioperative hypoglycemia
From into the grop to 1 month after surgery. And confirmed based on the patient's main complaint and monitoring records.
EFFICACY: Time required for blood glucose standard before surgery
the first hospital day
EFFICACY: Diabetes self-management behavior
Measurements were taken at baseline, day of hospitalization, and 1 month after discharge
EFFICACY: Incidence of perioperative adverse events
1 month after discharge
- +4 more secondary outcomes
Study Arms (2)
NP-Supported Multidisciplinary Diabetes Management
EXPERIMENTALNP establishes files to evaluate and manage patients before hospital and visits patients after hospitalization. Then set blood glucose control goals with endocrinology and orthopedic doctors together, initiates consultation with endocrinologists for patients with postoperative hyperglycemia, and is responsible for post-hospital follow-up.
Regular diabetes management
NO INTERVENTIONThe patient would go to the endocrinology outpatient clinic before hospitalization to regulate blood glucose, and be managed by by orthopedic medical staff through hospitalization. If necessary, the endocrinologist is consulted. And after the hospital, patients would be followed up by orthopedic medical staff.
Interventions
NP establishes files to evaluate and manage patients before hospital and visits patients after hospitalization. Then set blood glucose control goals with endocrinology and orthopedic doctors together, initiates consultation with endocrinologists for patients with postoperative hyperglycemia, and is responsible for post-hospital follow-up.
Eligibility Criteria
You may qualify if:
- Diagnosis meets World Health Organization (WHO) (1999) Diabetes Diagnostic Standards
- Orthopedic assessment requires elective surgery and no surgical contraindications
- HbA1c≥8.5% or intravenous fasting blood glucose (FBG)\>10mmol/l
- Informed consent.
You may not qualify if:
- Cognitive and communication disorders;
- Pregnancy;
- Participate in other intervention studies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Peking University Third Hospitallead
- Roche Pharma AGcollaborator
Related Publications (6)
Liao CC, Lin CS, Shih CC, Yeh CC, Chang YC, Lee YW, Chen TL. Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-based retrospective cohort studies. Diabetes Care. 2014 Aug;37(8):2246-52. doi: 10.2337/dc13-2957. Epub 2014 May 7.
PMID: 24804698BACKGROUNDMeneghini LF. Perioperative management of diabetes: translating evidence into practice. Cleve Clin J Med. 2009 Nov;76 Suppl 4:S53-9. doi: 10.3949/ccjm.76.s4.09.
PMID: 19880837BACKGROUNDClement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, Hirsch IB; American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004 Feb;27(2):553-91. doi: 10.2337/diacare.27.2.553. No abstract available.
PMID: 14747243BACKGROUNDSebranek JJ, Lugli AK, Coursin DB. Glycaemic control in the perioperative period. Br J Anaesth. 2013 Dec;111 Suppl 1:i18-34. doi: 10.1093/bja/aet381.
PMID: 24335396BACKGROUNDAminian A, Kashyap SR, Burguera B, Punchai S, Sharma G, Froylich D, Brethauer SA, Schauer PR. Incidence and Clinical Features of Diabetic Ketoacidosis After Bariatric and Metabolic Surgery. Diabetes Care. 2016 Apr;39(4):e50-3. doi: 10.2337/dc15-2647. Epub 2016 Jan 28. No abstract available.
PMID: 26822327BACKGROUNDGolden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999 Sep;22(9):1408-14. doi: 10.2337/diacare.22.9.1408.
PMID: 10480501BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 29, 2021
First Posted
March 23, 2022
Study Start
April 1, 2022
Primary Completion
March 31, 2023
Study Completion
March 31, 2023
Last Updated
March 23, 2022
Record last verified: 2021-12